Decrease of Pro-Angiogenic Monocytes Predicts Clinical Response to Anti-Angiogenic Treatment in Patients with Metastatic Renal Cell Carcinoma

Decrease of Pro-Angiogenic Monocytes Predicts Clinical Response to Anti-Angiogenic Treatment in Patients with Metastatic Renal Cell Carcinoma

The modulation of subpopulations of pro-angiogenic monocytes (VEGFR-1<sup>+</sup>CD14 and Tie2<sup>+</sup>CD14) was analyzed in an ancillary study from the prospective PazopanIb versus Sunitinib patient preferenCE Study (PISCES) (NCT01064310), where metastatic renal cell carc...

Full description

Bibliographic Details
Main Authors: Stephane Oudard, Nadine Benhamouda, Bernard Escudier, Patrice Ravel, Thi Tran, Emeline Levionnois, Sylvie Negrier, Philippe Barthelemy, Jean François Berdah, Marine Gross-Goupil, Cora N. Sternberg, Petri Bono, Camillo Porta, Ugo De Giorgi, Omi Parikh, Robert Hawkins, Martin Highley, Jochen Wilke, Thomas Decker, Corinne Tanchot, Alain Gey, Magali Terme, Eric Tartour
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Cells
Subjects:
angiogenesis
myeloid cells
biomarker
pro-angiogenic monocytes
renal cell carcinoma
Online Access:https://www.mdpi.com/2073-4409/11/1/17

Internet

https://www.mdpi.com/2073-4409/11/1/17

Similar Items